Leave Your Message

Unyango lwe-TIL lutyhilwe: Ukuphonononga i-Landscape ye-Cancer Immunotherapy

Unyango lwe-TILs lubandakanya ukukhupha i-tumor-infiltrating lymphocytes (TILs), ezona ziiseli ezichanekileyo zendalo ezichasene ne-tumor emzimbeni wesigulana, ukusuka kwithumba kwaye uzilime ngamanani amakhulu kwilebhu. Ezi TILs zisebenze ziphinda zifakwe emzimbeni wesigulana ukuze zomeleze amandla amajoni omzimba ekujoliseni nasekubulaleni iiseli zomhlaza. Ii-TILs zisebenza ngokuqaphela iimpawu ezithile kwiiseli zomhlaza kwaye ziqalise impendulo yokuzikhusela kuyo, ekugqibeleni ikhokelele ekutshatyalalisweni kwethumba.

    Yintoni iTils Therapy?

    Unyango lwe-TILs lubandakanya ukukhupha i-tumor-infiltrating lymphocytes (TILs), ezona ziiseli ezichanekileyo zendalo ezichasene ne-tumor emzimbeni wesigulana, ukusuka kwithumba kwaye uzilime ngamanani amakhulu kwilebhu. Ezi TILs zisebenze ziphinda zifakwe emzimbeni wesigulana ukuze zomeleze amandla amajoni omzimba ekujoliseni nasekubulaleni iiseli zomhlaza. Ii-TILs zisebenza ngokuqaphela iimpawu ezithile kwiiseli zomhlaza kwaye ziqalise impendulo yokuzikhusela kuyo, ekugqibeleni ikhokelele ekutshatyalalisweni kwethumba.

    Yintoni inkqubo yoNyango lweTils?

    AMAGQABANTSHINTSHI WONYANGO WE-CAR-T (3)3ypAMAGQABANTSHINTSHI WONYANGO LWECAR-T (4)mh0

    Iziphumo zeklinikhi zeTils Therapy

    Ngokusekelwe kwiziphumo zonyango lwethu lwezonyango, ukusebenza ngokupheleleyo kwe-TILs monotherapy ifikelela phezulu ukuya kuma-40%, iyenza ibe yeyona ndlela isebenzayo yonyango lwethumba ngaphandle kotyando olukhoyo ngoku.I-Bioocus ithunga isicwangciso sonyango esibanzi kwisigulane ngasinye. Enye okanye unyango oluninzi luya kudibaniswa nonyango lwe-Tils, oluya kwandisa izinga elisebenzayo lilonke ukuya ngaphezu kwe-80%. Unyango oludibeneyo lujolise ekunciphiseni umthwalo wethumba kwixesha elifutshane, kwaye i-tils inika ithuba lokuba isigulane sifumane unyango ekuhambeni kwexesha.

    Izinto eziluncedo kwiTils Therapy

    Ukucaciswa okuphezulu:iiseli T ithumba ezithile sensitized yi antigens ithumba, ziqatshelwe TCRs ezininzi

    I-tropism eyomeleleyo:ukubonakaliswa okuphezulu kwe-chemokine receptors, i-tumor tropism enamandla, kunye nesenzo esikhawulezayo

    Ukubulala amathumba:Ii-TILs ziyasebenza kwaye zandiswa ukuya kwi-109-1011, kwaye iiseli zomhlaza ezishiyekileyo ziyacinywa emva kotyando.

    Isiphumo esiqhubekayo:Ubungakanani beeseli ze-T zememori ziphezulu, kwaye zinokuphila emzimbeni ixesha elide kwaye zihlale zibekwe esweni.

    Ukhuseleko oluphezulu:ukukhutshwa, ukukhulisa, akukho mpendulo yokwaliwa, kunye ne-SAE yeeseli ze-TILs ezivela kwizigulane ngokwazo

    Iimpawu zoNyango lweTils

    Unyango lwe-Tils lubonakalise ukusebenza ngempumeleloI-NSCLC(umhlaza wemiphunga weseli ongeyiyo encinci),IMelanoma, uMhlaza wamabele,Umhlaza woMlomo weSibeleko,kunye noMhlaza we-Ovarian. 

    Zeziphi izihlunu ezinokusetyenziswa ukukhupha ii-TIL?

    Ngaphandle kokutsalwa kotyando lwe-tumor ephambili, izicubu ze-tumor ezingaphezulu, i-lymph nodes, i-pleural effusion, i-ascites, njl., inokuzanywa ukutsalwa. Uluhlu olusebenzayo lulandelayo: isilonda sokuqala ≥ i-metastatic lesion ≥ lymph nodes ≥ ascites.

    Ngaba zonke izigulana zingahlakulela ngempumelelo ii-TIL?

    Inkqubo yethu yokulima i-TILs ephuhliswe ngokuzimeleyo ifezekisa izinga lempumelelo ye-≥85%. Ngesampulu yethishu eqhelekileyo ≥1cm3, iibhiliyoni zee-TIL zinokulinywa, kwaye iiseli zibonisa umsebenzi owomeleleyo we-cytotoxic."

    Iziphumo ebezingalindelekanga zonyango lwe-TILs?

    I-1.TILs ziiseli zesigulane, ngoko akukho mngcipheko wokugatywa, ukuqinisekisa ukhuseleko oluphezulu.

    2. Ukusabela okungathandekiyo: Umkhuhlane uxhaphakile (ngenxa yokukhululwa kwee-cytokines ngexesha le-TILs ye-cell-mediated tumor clearance, ebangela umkhuhlane wexeshana, ngokuqhelekileyo awufuni unyango oluthile kwaye uzisombulule ngokwawo).

    I-3.Ezinye iziphumo ezimbi ezichazwe kwizifundo ziquka i-thrombocytopenia, i-febrile neutropenia, i-hypertension, njl., ubukhulu becala kubangelwa ii-TILs ngokudibanisa nezinye iziyobisi ezifana ne-chemotherapy yangaphambili (i-cyclophosphamide + fluorouracil), i-high-dose IL-2, i-PD-1 ii-antibodies ze-monoclonal, njl.

    AMAGQABANTSHINTSHI WONYANGO LWECAR-T (5)yz0

    inkcazelo2

    Fill out my online form.